Higher myocarditis risk after COVID-19 than mRNA vaccination; contrary to Peter McCullough’s claim, young persons decrease their risk by getting vaccinated

Myocarditis, an inflammation in the heart muscle, is typically caused by viral infections. In rare instances, myocarditis can also occur after COVID-19 vaccination. During the global COVID-19 vaccination campaign, the mRNA vaccines have been linked to rare cases of post-vaccine myocarditis that are usually mild and resolve; these have occurred primarily in young males. On the other hand, COVID-19 itself carries a much higher risk of heart complications, including myocarditis. Moreover, the COVID-19 vaccines decrease the risk of COVID-19-related myocarditis, meaning that COVID-19 vaccination continues to be recommended to young persons.

Contrary to Peter McCullough’s claim, getting vaccinated is safer than getting COVID-19, in spite of rare cases of myocarditis

Although cases of myocarditis have been reported following mRNA vaccination against COVID-19, the cases are rare, usually mild and patients rapidly recover. In contrast, COVID-19 is associated with a higher rate of myocarditis with potential risks of clinical complications. Overall, based on all scientific evidence available, the benefits of vaccines largely outweigh their risks.

Joe Rogan interview with Peter McCullough contains multiple false and unsubstantiated claims about the COVID-19 pandemic and vaccines

To date, more than 241 million people in the U.S. have received at least one dose of COVID-19 vaccine. Clinical trials as well as the safety monitoring of COVID-19 vaccination campaigns provide overwhelming evidence that the vaccines’ benefits far outweigh their risks. There’s no evidence indicating that the amount of spike protein generated by mRNA vaccination is dangerous. The use of multiple doses of COVID-19 vaccines isn’t unusual or unprecedented; some childhood vaccines that have been used for decades also require four or more doses for complete immunization.

Vaccines are a safer alternative for acquiring immunity compared to natural infection and COVID-19 survivors benefit from getting vaccinated, contrary to claims by Peter McCullough

Clinical trials showed that COVID-19 vaccines are effective against the disease and have an excellent safety profile. While infection can also confer protective immunity, this also comes with the risks associated with disease, such as death and health complications. Vaccination develops immunity without running these risks, making vaccines the safer choice. COVID-19 survivors also benefit from vaccination. For example, vaccination may help prevent reinfection in survivors who don’t develop protective immunity from infection alone, while vaccine boosters can help build immunity to virus variants.

Comparing SARS-CoV-2 infection rate of vaccinated and unvaccinated populations doesn’t reflect the real COVID-19 vaccine effectiveness

Vaccinated and unvaccinated populations may differ in many characteristics, such as age, population size, social behavior or health seeking behavior. These differences must be taken into consideration when comparing the SARS-CoV-2 infection rates between vaccinated and unvaccinated populations. Failure to do so may lead to biased conclusions. Studies accounting for these differences showed that COVID-19 vaccines effectively reduce the risk of getting sick.

Study in Vietnam showed that Delta infection results in a higher viral load compared to earlier strains, not that vaccinated people are more infectious than unvaccinated people

Multiple studies indicate that Delta variant infection results in a higher viral load compared to infection by the original strain and other variants. However, COVID-19 vaccination remains highly effective at protecting people from illness and hospitalization caused by the Delta variant, which is now the predominant strain in the world. And while the level of protection from infection by vaccines is lower against the Delta variant, vaccinated people still have a lower risk of infection compared to those who are unvaccinated.

The American Journal of Medicine didn’t recommend hydroxychloroquine as a treatment for COVID-19; scientific evidence doesn’t show hydroxychloroquine is effective against COVID-19

No scientific evidence demonstrates that hydroxychloroquine is useful for preventing or treating COVID-19, despite social media posts and articles claiming otherwise. Large, randomized, controlled clinical trials in several countries found that hydroxychloroquine doesn’t produce any benefits in terms of mortality rate or clinical outcomes in COVID-19 patients. Due to the lack of benefits and risk of heart rhythm problems, public health authorities recommend against using hydroxychloroquine to treat COVID-19 patients outside of clinical trials.